Fluorodeoxyglucose PET in Neurology and Psychiatry.
PET Clin
; 9(4): 371-90, v, 2014 Oct.
Article
in En
| MEDLINE
| ID: mdl-26050943
ABSTRACT
PET imaging with the most widely available PET tracer, 2-deoxy-2-[(18)F]fluoro-d-glucose (FDG), is a powerful tool in the differential diagnosis of numerous neurologic and psychiatric disorders, particularly in early disease stages. It also plays an important role in the longitudinal evaluation of treatment effects and the depiction of disease courses. A selection of established and eligible application areas of FDG PET in neurology and psychiatry, such as different types of dementia, epilepsy, schizophrenia, and bipolar disorder, are reviewed in this article. A general methodology for clinical FDG PET examinations and typical diagnostic criteria and pitfalls are addressed.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Diseases
/
Radiopharmaceuticals
/
Fluorodeoxyglucose F18
/
Positron-Emission Tomography
/
Mental Disorders
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
PET Clin
Year:
2014
Document type:
Article